Nanospectra Biosciences, Inc.
Ultra-focal, Patient focused - Leveraging nanoshells in the first true focal therapy
Houston, United States
4 employees
Series Unknown
Total: $16.66M
Biotechnology, Health Care +2
General Information
Get notified when Nanospectra Biosciences, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Nanospectra Biosciences, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Nanospectra Biosciences, Inc.
Taxonomy: nanoshells, nanomedicine, medical device company, thermal ablation, prostate cancer, patient-centric, AuroLase Therapy, clinical advancements, particle-based therapies, solid tumors, oncology, precision medicine, nanoparticles, Houston, Texas
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 15 Mar 2023 | |
| Series B | •••••• | 1 | •••• •••• | 08 Sep 2020 |
| Venture Round | •••••• | - | 09 Feb 2017 | |
| Venture Round | •••••• | - | 12 Dec 2015 | |
| Venture Round | •••••• | - | 08 Sep 2014 |
Nanospectra Biosciences, Inc. Alternatives & Competitors
A LEADING COMPANY IN IMAGE-GUIDED LASER TUMOR THERAPY
Welcome to the official Focal account, French brand of hi-fi loudspeakers, drivers, monitors and hea...
Pioneering microwave ablation treatment for early stage lung cancer
FAQ About Nanospectra Biosciences, Inc.
Don't just browse. Track.
Signal Tracker monitors Nanospectra Biosciences, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
